This detailed review of JM Midcap Fund evaluates its recent performance, comparing it to the Nifty index, and analyzes key ...

As 2024 has come and passed, we saw another year of significant developments in litigation involving biologics and biosimilars. The ...

Indian financial markets are expected to remain volatile in the first half of 2025 amid global and domestic uncertainties, ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...

HomeAdvisor provides a snapshot of each company with relevant information such as services, reviews and phone numbers. As you compare options, you can directly reach out to HomeAdvisor by phone or ...

Biocon share price: This upgrade reflects a more positive outlook on the company following recent favorable news flow, particularly concerning its biologics business. Stocks to buy today: CLSA ...

Biocon stock price has broken out from the upper band of a Symmetrical Triangle formation, indicating a positive movement. Traders can buy for a target of Rs 403-436 in the next 3-4 weeks,” Kkunal V.

According to the Sebi mandate, the large cap mutual funds are mandated to invest in top 100 companies by market capitalisation. Large companies fare better in a volatile market as these companies may ...

This initiative aligns with the government’s focus on clean energy and may offer long-term benefits for the company. Biocon Pharma, a subsidiary of Biocon, has received approval from China’s National ...